PHILADELPHIA, June 19, 2019: Morgan Lewis represented Nevakar Inc. in a $50 million product financing agreement with an affiliate of NovaQuest Capital Management LLC for the continued development of five differentiated, sterile injectable products.
Nevakar is a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas. NovaQuest is an investor in life sciences and healthcare focused on reducing the cost of healthcare, addressing unmet medical needs, improving safety, and enhancing overall quality of life.
Partner Joanne Soslow led the Morgan Lewis team advising Nevakar.